Abstract
High level expression and efficient recovery of recombinant protein aretwo main critical factors that determine the use of transgenic plants asnaturalbioreactors to produce foreign proteins for industrial applications. Wedemonstrate here the potential of a new strategy involving chloroplasttransformation, GUS-fusions and affinity-tag based chromatography tooverexpressand purify a human therapeutic protein, interferon gamma (IFN-g) in tobaccoplants. Our results show that IFN-g accumulation reaches up to 6% of totalsolubleprotein when expressed as a GUS-fusion protein in tobacco chloroplasts.Additionof His-tag simplified the downstream process and the recombinant protein yieldswere considerably high (∼360 μg/g fresh leaf tissue).Further we demonstrate the use of GUS-fusions to identify recombinant proteincontaining fractions very rapidly (< 5 minutes) through simple GUS assay, animportant consideration for those proteins that are highly labile duringlengthyand harsh downstream processing conditions. The chloroplast-produced IFN-g isbiologically as active as the same protein obtained through E.coli expression without any involvement of refolding procedure. Ourresults demonstrate that the new strategy has tremendous potential for largescale production of proteins from heterologous source, independent of theirphysio-chemical and biological properties, using plants as ‘naturalbioreactors’.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.